| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.495 | 0.011 | 0.495 | RNA-directed DNA polymerase inhibitor | 0.467 0.013 CID_154699692 | ||
| 0.48 | 0.004 | 0.48 | HIV-1 reverse transcriptase inhibitor | 0.284 0.005 CID_154699692 | ||
| 0.346 | 0.038 | 0.346 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.318 | 0.033 | 0.318 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.28 | 0.008 | 0.28 | DNA directed RNA polymerase inhibitor | 0.187 0.015 CID_154699692 | ||
| 0.302 | 0.034 | 0.302 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.269 | 0.022 | 0.269 | Nitric-oxide synthase stimulant | 0.253 0.03 CID_154699692 | ||
| 0.363 | 0.136 | 0.363 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.319 | 0.118 | 0.319 | MAP kinase kinase 6 inhibitor | |||
| 0.222 | 0.029 | 0.222 | Ribosomal protein S6 kinase inhibitor | 0.152 0.063 CID_154699692 | ||
| 0.195 | 0.008 | 0.195 | Phosphodiesterase 4B inhibitor | |||
| 0.236 | 0.056 | 0.236 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.209 | 0.033 | 0.209 | Activin receptor-like kinase 2 inhibitor | |||
| 0.234 | 0.062 | 0.234 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.181 | 0.016 | 0.181 | Phosphodiesterase IV inhibitor | |||
| 0.24 | 0.079 | 0.24 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.19 | 0.038 | 0.19 | Phosphodiesterase inhibitor | |||
| 0.222 | 0.08 | 0.222 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.183 | 0.051 | 0.183 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.204 | 0.072 | 0.204 | Death-associated protein kinase 3 inhibitor | |||
| 0.16 | 0.03 | 0.16 | 5 Hydroxytryptamine 3A agonist | |||
| 0.221 | 0.093 | 0.391 | DNA synthesis inhibitor | 0.391 0.023 CID_154699692 | CID_154699692 | |
| 0.171 | 0.047 | 0.171 | Cyclin-dependent kinase inhibitor | |||
| 0.139 | 0.016 | 0.139 | Cyclin B3 inhibitor | |||
| 0.163 | 0.042 | 0.163 | Glutamate receptor antagonist | |||
| 0.155 | 0.041 | 0.155 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.188 | 0.074 | 0.188 | TRKC antagonist | |||
| 0.155 | 0.044 | 0.155 | Glycogen synthase kinase-3 inhibitor | |||
| 0.173 | 0.063 | 0.173 | Death-associated protein kinase 2 inhibitor | |||
| 0.148 | 0.042 | 0.148 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.122 | 0.018 | 0.122 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.178 | 0.078 | 0.178 | CDC-like kinase 2 inhibitor | |||
| 0.253 | 0.153 | 0.451 | Histamine release inhibitor | 0.451 0.05 CID_154699692 | CID_154699692 | |
| 0.104 | 0.005 | 0.104 | Nicotinic acid receptor agonist | |||
| 0.166 | 0.068 | 0.166 | Polo-like kinase-3 inhibitor | |||
| 0.125 | 0.029 | 0.125 | Protein kinase C zeta inhibitor | |||
| 0.251 | 0.156 | 0.375 | Antiobesity | 0.375 0.076 CID_154699692 | CID_154699692 | |
| 0.143 | 0.051 | 0.143 | Death-associated protein kinase 1 inhibitor | |||
| 0.104 | 0.014 | 0.104 | CDK4/cyclin D1 inhibitor | |||
| 0.132 | 0.043 | 0.132 | Protein kinase C gamma inhibitor | |||
| 0.105 | 0.021 | 0.105 | Polo-like kinase-2 inhibitor | |||
| 0.09 | 0.006 | 0.09 | Nicotinic acid receptor 2 agonist | |||
| 0.145 | 0.068 | 0.145 | MAP3K9 inhibitor | |||
| 0.134 | 0.063 | 0.134 | Protein kinase (CK1) delta inhibitor | |||
| 0.086 | 0.019 | 0.086 | CDK4/cyclin D inhibitor | |||
| 0.077 | 0.011 | 0.077 | Nicotinic acid receptor 1 agonist | |||
| 0.196 | 0.133 | 0.196 | MAP kinase kinase 3 inhibitor | |||
| 0.081 | 0.017 | 0.081 | Phosphodiesterase II inhibitor | |||
| 0.119 | 0.057 | 0.119 | Polo-like kinase-4 inhibitor | |||
| 0.145 | 0.084 | 0.145 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.103 | 0.043 | 0.103 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.152 | 0.092 | 0.152 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.141 | 0.082 | 0.141 | MAP kinase kinase 4 inhibitor | |||
| 0.099 | 0.04 | 0.099 | MAP-kinase-activated kinase inhibitor | |||
| 0.087 | 0.031 | 0.103 | Phosphodiesterase VI inhibitor | 0.103 0.018 CID_154699692 | CID_154699692 | |
| 0.108 | 0.052 | 0.108 | Creatine kinase inhibitor | |||
| 0.071 | 0.017 | 0.071 | Phosphodiesterase 2A inhibitor | |||
| 0.168 | 0.116 | 0.168 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.098 | 0.046 | 0.098 | Protein kinase A inhibitor | |||
| 0.161 | 0.111 | 0.161 | MAP kinase kinase 2 inhibitor | |||
| 0.11 | 0.06 | 0.11 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.086 | 0.039 | 0.086 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.071 | 0.025 | 0.071 | Fatty acid synthase inhibitor | |||
| 0.147 | 0.101 | 0.147 | LIM domain kinase 1 inhibitor | |||
| 0.091 | 0.045 | 0.091 | mTOR complex 2 inhibitor | |||
| 0.104 | 0.058 | 0.109 | Folate antagonist | 0.109 0.051 CID_154699692 | CID_154699692 | |
| 0.071 | 0.03 | 0.071 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.076 | 0.036 | 0.076 | Protein kinase C beta inhibitor | |||
| 0.131 | 0.092 | 0.131 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.091 | 0.053 | 0.091 | Bromodomain-containing protein 2 inhibitor | |||
| 0.162 | 0.125 | 0.162 | Dyrk kinase inhibitor | |||
| 0.066 | 0.031 | 0.066 | Protein kinase C eta inhibitor | 0.052 0.041 CID_154699692 | ||
| 0.149 | 0.115 | 0.149 | Clk dual-specificity kinase inhibitor | |||
| 0.098 | 0.066 | 0.098 | Bronchodilator | |||
| 0.141 | 0.109 | 0.141 | CDC-like kinase 4 inhibitor | |||
| 0.09 | 0.059 | 0.09 | CDK/cyclin complex inhibitor | |||
| 0.092 | 0.061 | 0.092 | Protein kinase C delta inhibitor | |||
| 0.247 | 0.217 | 0.702 | Cyclophilin D inhibitor | 0.702 0.014 CID_154699692 | CID_154699692 | |
| 0.052 | 0.022 | 0.052 | Benzodiazepine inverse agonist | |||
| 0.049 | 0.019 | 0.049 | DNA gyrase subunit A inhibitor | 0.04 0.035 CID_154699692 | ||
| 0.134 | 0.106 | 0.134 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.059 | 0.033 | 0.059 | Cyclin B2 inhibitor | |||
| 0.126 | 0.1 | 0.126 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.147 | 0.123 | 0.147 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.053 | 0.029 | 0.053 | AMPA receptor antagonist | |||
| 0.063 | 0.04 | 0.063 | Cyclin B1 inhibitor | |||
| 0.118 | 0.095 | 0.118 | Protein kinase C nu inhibitor | |||
| 0.117 | 0.094 | 0.117 | Protein kinase (CK1) inhibitor | |||
| 0.069 | 0.048 | 0.069 | Protein kinase B alpha inhibitor | |||
| 0.089 | 0.069 | 0.089 | Protein kinase C mu inhibitor | |||
| 0.149 | 0.13 | 0.149 | EphB2 antagonist | |||
| 0.26 | 0.241 | 0.287 | Caspase 9 stimulant | 0.287 0.208 CID_154699692 | CID_154699692 | |
| 0.068 | 0.05 | 0.068 | CDK1/cyclin B1 inhibitor | |||
| 0.05 | 0.032 | 0.05 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.076 | 0.059 | 0.076 | MAP kinase kinase 7 inhibitor | |||
| 0.062 | 0.046 | 0.062 | 5 Hydroxytryptamine 3 agonist | |||
| 0.036 | 0.019 | 0.036 | CDK6/cyclin D3 inhibitor | |||
| 0.035 | 0.019 | 0.035 | Protein kinase C beta I inhibitor | 0.034 0.02 CID_154699692 | ||
| 0.154 | 0.138 | 0.154 | MAP kinase kinase 5 inhibitor | |||
| 0.07 | 0.057 | 0.07 | Protein kinase B beta inhibitor | |||
| 0.031 | 0.018 | 0.031 | DNA topoisomerase IV inhibitor | 0.029 0.023 CID_154699692 | ||
| 0.026 | 0.015 | 0.026 | Phosphodiesterase 9A inhibitor | |||
| 0.025 | 0.014 | 0.025 | Phosphodiesterase IX inhibitor | |||
| 0.078 | 0.067 | 0.078 | Caspase 7 inhibitor | |||
| 0.106 | 0.095 | 0.106 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.263 | 0.253 | 0.633 | Antiinflammatory | 0.633 0.045 CID_154699692 | CID_154699692 | |
| 0.127 | 0.118 | 0.127 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.051 | 0.044 | 0.051 | Cyclin B inhibitor | |||
| 0.081 | 0.074 | 0.081 | Phosphodiesterase I inhibitor | |||
| 0.152 | 0.149 | 0.319 | Cyclic AMP phosphodiesterase inhibitor | 0.319 0.035 CID_154699692 | CID_154699692 | |
| 0.061 | 0.059 | 0.061 | Protein kinase C alpha inhibitor | |||
| 0.031 | 0.03 | 0.031 | RNA-directed RNA polymerase inhibitor | |||
| 0.096 | 0.098 | 0.098 | Acetylcholine release stimulant | 0.098 0.093 CID_154699692 | CID_154699692 | |
| 0.105 | 0.111 | 0.193 | DNA repair enzyme inhibitor | 0.193 0.01 CID_154699692 | CID_154699692 | |
| 0.05 | 0.066 | 0.089 | DNA gyrase inhibitor | 0.089 0.022 CID_154699692 | CID_154699692 | |
| 0.188 | 0.211 | 0.362 | Interleukin 2 agonist | 0.362 0.04 CID_154699692 | CID_154699692 | |
| 0.081 | 0.104 | 0.12 | Phosphodiesterase 6D inhibitor | 0.12 0.025 CID_154699692 | CID_154699692 | |
| 0.136 | 0.161 | 0.149 | Neurotrophic factor enhancer | 0.149 0.139 CID_154699692 | CID_154699692 | |
| 0.113 | 0.152 | 0.196 | Interferon gamma antagonist | 0.196 0.042 CID_154699692 | CID_154699692 | |
| 0.164 | 0.211 | 0.409 | Immunomodulator | 0.409 0.041 CID_154699692 | CID_154699692 | |
| 0.1 | 0.157 | 0.237 | Hexokinase inhibitor | 0.237 0.02 CID_154699692 | CID_154699692 | |
| 0.062 | 0.134 | 0.131 | UDP-glucose 4-epimerase inhibitor | 0.131 0.037 CID_154699692 | CID_154699692 | |
| 0.212 | 0.287 | 0.308 | 5 Hydroxytryptamine release inhibitor | 0.308 0.156 CID_154699692 | CID_154699692 | |
| 0.07 | 0.149 | 0.107 | Multidrug resistance-associated protein 1 inhibitor | 0.107 0.066 CID_154699692 | CID_154699692 | |
| 0.107 | 0.209 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.053 CID_154699692 | CID_154699692 | |
| 0.056 | 0.161 | 0.093 | NADH dehydrogenase inhibitor | 0.093 0.052 CID_154699692 | CID_154699692 | |
| 0.017 | 0.129 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 CID_154699692 | CID_154699692 | |
| 0.061 | 0.173 | 0.148 | Beta glucuronidase inhibitor | 0.148 0.026 CID_154699692 | CID_154699692 | |
| 0.044 | 0.16 | 0.144 | Topoisomerase I inhibitor | 0.144 0.044 CID_154699692 | CID_154699692 | |
| 0.086 | 0.206 | 0.21 | NOS3 expression enhancer | 0.21 0.037 CID_154699692 | CID_154699692 | |
| 0.182 | 0.302 | 0.476 | Apoptosis agonist | 0.476 0.082 CID_154699692 | CID_154699692 | |
| 0.057 | 0.189 | 0.226 | AMP-activated protein kinase stimulant | 0.226 0.008 CID_154699692 | CID_154699692 | |
| 0.047 | 0.181 | 0.155 | Topoisomerase II inhibitor | 0.155 0.047 CID_154699692 | CID_154699692 | |
| 0.099 | 0.236 | 0.341 | Tumour necrosis factor alpha release inhibitor | 0.341 0.04 CID_154699692 | CID_154699692 | |
| 0.145 | 0.285 | 0.343 | Apoptosis antagonist | 0.343 0.059 CID_154699692 | CID_154699692 | |
| 0.06 | 0.21 | 0.092 | Interleukin 12 antagonist | 0.092 0.068 CID_154699692 | CID_154699692 | |
| 0.087 | 0.239 | 0.183 | Hypolipemic | 0.183 0.107 CID_154699692 | CID_154699692 | |
| 0.073 | 0.225 | 0.179 | Cell wall synthesis inhibitor | 0.179 0.041 CID_154699692 | CID_154699692 | |
| 0.041 | 0.199 | 0.117 | Mediator release inhibitor | 0.117 0.05 CID_154699692 | CID_154699692 | |
| 0.078 | 0.257 | 0.209 | Insulin secretagoues | 0.209 0.031 CID_154699692 | CID_154699692 | |
| 0.017 | 0.204 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 CID_154699692 | CID_154699692 | |
| 0.112 | 0.305 | 0.286 | Angiogenesis inhibitor | 0.286 0.1 CID_154699692 | CID_154699692 | |
| 0.078 | 0.274 | 0.172 | Spasmolytic | 0.172 0.143 CID_154699692 | CID_154699692 | |
| 0.072 | 0.27 | 0.226 | Interleukin agonist | 0.226 0.098 CID_154699692 | CID_154699692 | |
| 0.015 | 0.217 | 0.1 | Antineoplastic antibiotic | 0.1 0.046 CID_154699692 | CID_154699692 | |
| 0.036 | 0.244 | 0.055 | Lipocortins synthesis agonist | 0.055 0.049 CID_154699692 | CID_154699692 | |
| 0.072 | 0.289 | 0.282 | Hemostatic | 0.282 0.018 CID_154699692 | CID_154699692 | |
| 0.053 | 0.273 | 0.468 | Angiogenesis stimulant | 0.468 0.014 CID_154699692 | CID_154699692 | |
| 0.055 | 0.294 | 0.137 | Diuretic | 0.137 0.088 CID_154699692 | CID_154699692 | |
| 0.108 | 0.376 | 0.322 | Peptidyltransferase inhibitor | 0.322 0.018 CID_154699692 | CID_154699692 | |
| 0.037 | 0.314 | 0.157 | Lipid peroxidase inhibitor | 0.157 0.063 CID_154699692 | CID_154699692 | |
| 0.065 | 0.35 | 0.244 | Vasodilator | 0.244 0.073 CID_154699692 | CID_154699692 | |
| 0.059 | 0.348 | 0.14 | Interleukin 6 antagonist | 0.14 0.105 CID_154699692 | CID_154699692 | |
| 0.012 | 0.312 | 0.266 | Selectin antagonist | 0.266 0.007 CID_154699692 | CID_154699692 | |
| 0.052 | 0.359 | 0.211 | Platelet antagonist | 0.211 0.094 CID_154699692 | CID_154699692 | |
| 0.097 | 0.404 | 0.549 | Antibacterial | 0.549 0.029 CID_154699692 | CID_154699692 | |
| 0.049 | 0.38 | 0.216 | Platelet adhesion inhibitor | 0.216 0.063 CID_154699692 | CID_154699692 | |
| 0.03 | 0.365 | 0.23 | Thrombolytic | 0.23 0.039 CID_154699692 | CID_154699692 | |
| 0.014 | 0.35 | 0.055 | Antibiotic Aminoglycoside-like | 0.055 0.01 CID_154699692 | CID_154699692 | |
| 0.063 | 0.425 | 0.313 | Transcription factor NF kappa B inhibitor | 0.313 0.088 CID_154699692 | CID_154699692 | |
| 0.05 | 0.417 | 0.355 | Antioxidant | 0.355 0.045 CID_154699692 | CID_154699692 | |
| 0.016 | 0.395 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 CID_154699692 | CID_154699692 | |
| 0.04 | 0.431 | 0.317 | Free radical scavenger | 0.317 0.047 CID_154699692 | CID_154699692 | |
| 0.035 | 0.429 | 0.296 | Immunostimulant | 0.296 0.079 CID_154699692 | CID_154699692 | |
| 0.041 | 0.439 | 0.221 | Nitric oxide antagonist | 0.221 0.06 CID_154699692 | CID_154699692 | |
| 0.005 | 0.44 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 CID_154699692 | CID_154699692 | |
| 0.066 | 0.513 | 0.212 | Vasodilator, coronary | 0.212 0.171 CID_154699692 | CID_154699692 | |
| 0.05 | 0.497 | 0.364 | Immunosuppressant | 0.364 0.079 CID_154699692 | CID_154699692 | |
| 0.034 | 0.49 | 0.09 | Transcription factor NF kappa B stimulant | 0.09 0.051 CID_154699692 | CID_154699692 | |
| 0.018 | 0.476 | 0.089 | ATPase (Vacuolar H+) inhibitor | 0.089 0.058 CID_154699692 | CID_154699692 | |
| 0.013 | 0.509 | 0.051 | Heparanase inhibitor | 0.051 0.041 CID_154699692 | CID_154699692 | |
| 0.025 | 0.534 | 0.127 | Cell adhesion inhibitor | 0.127 0.06 CID_154699692 | CID_154699692 | |
| 0.043 | 0.552 | 0.347 | Antithrombotic | 0.347 0.066 CID_154699692 | CID_154699692 | |
| 0.025 | 0.552 | 0.107 | Toll-Like receptor 4 antagonist | 0.107 0.059 CID_154699692 | CID_154699692 | |
| 0.036 | 0.594 | 0.267 | Hepatoprotectant | 0.267 0.039 CID_154699692 | CID_154699692 | |
| 0.013 | 0.627 | 0.128 | Anticoagulant | 0.128 0.103 CID_154699692 | CID_154699692 | |
| 0.034 | 0.669 | 0.414 | Hypoglycemic | 0.414 0.025 CID_154699692 | CID_154699692 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |